S1R Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Shanghai Pharmaceuticals Holding Co Ltd

Watchlist Manager

Watchlist

Price: 1.3 EUR -0.76% Market Closed

Market Cap: €6.2B

S	Shanghai Pharmaceuticals Holding Co Ltd F:S1R	CN
H	Harvey Norman Holdings Ltd F:HNN	AU
	Merdeka Copper Gold Tbk PT OTC:PMCGF	ID
S	SBA Communications Corp F:4SB	US
S	Silvercorp Metals Inc F:S9Y	CA
P	Precigen Inc F:I5X	US
A	Axon Enterprise Inc XMUN:TCS	US
A	AXA SA XHAM:AXA	FR
P	Philip Morris International Inc XBER:4I1	US
E	Exelon Corp XBER:PEO	US
M	Mitsubishi UFJ Financial Group Inc SGX:N5YD	JP
C	Conduent Inc F:4C0	US

Profitability Summary

Shanghai Pharmaceuticals Holding Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

11%

Sustainable 3Y Average Gross Margin

11%

Declining Gross Margin

13% > 11%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 2%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.